SCHEMBL19682107

SCHEMBL19682107

CCCCCCCCCCO[C@@H](C)C(CO)O[C@H](OC)[C@H](O)CO

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MGAM O43451 3/20 0.38
USP2 O75604 1/20 0.38
SPHK1 Q9NYA1 2/20 0.35
ALDH1A1 P00352 1/20 0.34
CNR1 P21554 1/20 0.34
CNR2 P34972 1/20 0.34
LPAR6 P43657 2/20 0.33
LPAR1 Q92633 2/20 0.33
LPAR4 Q99677 2/20 0.33
LPAR5 Q9H1C0 2/20 0.33
LPAR2 Q9HBW0 2/20 0.33
LPAR3 Q9UBY5 2/20 0.33
DNM1 Q05193 1/20 0.33
CYP2D6 P10635 2/20 0.33
MAPT P10636 2/20 0.33
HTT P42858 2/20 0.33
GMNN O75496 1/20 0.33
LMNA P02545 1/20 0.33
POLB P06746 1/20 0.33
THPO P40225 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19682026 1.00 MGAM (0.38) MGAMUSP2SPHK1ALDH1A1CNR1
SCHEMBL19682032 1.00 MGAM (0.38) MGAMUSP2SPHK1ALDH1A1CNR1
SCHEMBL19682119 1.00 MGAM (0.38) MGAMUSP2SPHK1ALDH1A1CNR1
SCHEMBL19682021 0.98 MGAM (0.37) MGAMUSP2SPHK1ALDH1A1CNR1
SCHEMBL10590769 0.82 USP2 (0.42) MGAMUSP2ALDH1A1CNR1CNR2
SCHEMBL10593128 0.82 USP2 (0.42) MGAMUSP2ALDH1A1CNR1CNR2
SCHEMBL4649577 0.82 USP2 (0.46) MGAMUSP2SPHK1ALDH1A1CNR1
SCHEMBL10594537 0.82 USP2 (0.42) MGAMUSP2ALDH1A1CNR1CNR2
SCHEMBL19682023 0.80 USP2 (0.50) USP2SPHK1LPAR6LPAR1LPAR4
SCHEMBL22404805 0.80 USP2 (0.50) USP2SPHK1LPAR6LPAR1LPAR4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170347653-A1 ANTIBACTERIAL COMPOSITION CONTAINING AN ISOMER MIXTURE OF MONOSACCHARIDE ALKYL MONOACETALS OR MONOETHERS CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) 2017-12-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170347653-A1 ANTIBACTERIAL COMPOSITION CONTAINING AN ISOMER MIXTURE OF MONOSACCHARIDE ALKYL MONOACETALS OR MONOETHERS GNE, MGAM, GALE MGAM 2/4885USP2 286/4885SPHK1 3853/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.